Alpha-MSH vs Melanotan I — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Alpha-melanocyte stimulating hormone (alpha-MSH) is a 13-amino acid endogenous peptide cleaved from pro-opiomelanocortin (POMC). Unlike its synthetic analog Melanotan-2 which primarily activates MC1R and MC4R for pigmentation and sexual function, alpha-MSH is best recognized for ...
Calculate Alpha-MSH dose →Afamelanotide (Melanotan I, Scenesse) is an FDA-approved synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It was approved in 2019 for prevention of phototoxicity in adults with erythropoietic protoporphyria (EPP)....
Calculate Melanotan I dose →| Parameter | Alpha-MSH | Melanotan I |
|---|---|---|
| Category | Melanocortin Peptide | Melanocortin Peptide |
| Research | Clinical | FDA Approved |
| Half-Life | 10-20 min (plasma) | 24-36 hours (implant) |
| Typical Dose | 10-50 mcg (intranasal) | 16 mg per implant |
| Frequency | Variable | Every 60 days |
| Route | Intranasal, Subcutaneous, IV | Subcutaneous implant (16 mg) |
| FDA Status | Not approved | Approved (EPP, 2019) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.